If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to (7), (9), and (11): Includes (i) 12,346,326 shares beneficially owned by the Reporting Person (which number, as of the filing date of this Amendment No. 3 to Schedule 13D, includes 67,474 shares issuable upon the future vesting of currently unvested portions of a restricted stock unit award granted to the Reporting Person), (ii) 119,466 shares issuable upon the exercise of outstanding options held by the Reporting Person that are currently exercisable or exercisable within 60 days following the filing date of this Amendment No. 3 to Schedule 13D, and (iii) 947,370 shares owned by Cerro Gordo LLC ("CGL"). The Reporting Person has sole voting and investment power over shares of the issuer held by CGL. Note to (13): Based on 33,764,222 shares of Common Stock outstanding as of September 2, 2026, plus 119,466 shares purchasable upon the exercise of outstanding options held by the Reporting Person that are currently exercisable or exercisable within 60 days following the filing date of the Amendment No. 3 to Schedule 13D.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to (13): Based on 33,764,222 shares of Common Stock outstanding as of September 2, 2026.


SCHEDULE 13D


 
Charles Youakim
 
Signature:Charles Youakim
Name/Title:Charles Youakim
Date:09/10/2026
 
Cerro Gordo LLC
 
Signature:Cerro Gordo LLC
Name/Title:Charles Youakim
Date:09/10/2026